CURE.AS shareholders have already approved the merger. If OPGN’s shareholder vote on 3/30/20 proceeds without a hitch, the merger will close immediately thereafter.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”